by
Barbara Kram, Editor | November 07, 2005
VEENENDAAL, THE NETHERLANDS - October 28, 2005 - Nucletron B.V., a global leader providing some of the world's most innovative products and services for cancer treatment, has received 510(k) clearance from the U.S. Food and Drug Administration for Oncentra ConeBeam.
Oncentra ConeBeam is a break-through method of acquiring and reconstructing CT images from 3D isotropic data. Used in conjunction with the Simulix Evolution simulator, Oncentra ConeBeam creates a unique radiation therapy imaging tool that can perform conventional and CT assisted simulation on the same platform, providing clinicians the best of both techniques.
"We are using our experience from around the world to develop relevant clinical tools," said David Imperiali, Managing Director of Nucletron. "Oncentra ConeBeam offers the oncology team the opportunity to more easily incorporate CT images in radiation treatment planning. We aim to provide imaging techniques that improve precision and productivity."
Greater Baltimore Medical Center, Baltimore, Maryland is the first site in the United States using Oncentra ConeBeam clinically. As part of a gamma test, the Center has shown good results with cone beam CT imaging for both breast, and head and neck in treatment planning.
Dr. Robert Brookland, Director of Radiation Oncology at Greater Baltimore Medical Center, Baltimore, MD states, "We are pleased with the new Oncentra ConeBeam imaging system installed on our Simulix Evolution. For our breast cancer patients we are able to perform digital fluoroscopy and acquire a volume of CT data with the patient in the true treatment position. Oncentra ConeBeam allows us to create a 3D treatment plan, optimizing the dose and providing a better treatment planning outcome. Our center is a long standing Simulix user and the addition of Oncentra ConeBeam further demonstrates Nucletron's commitment to keeping its customers on the forefront of technology through upgrade opportunities."
For more information on Nucletron, please visit:
www.nucletron.com.